Monashee Investment Management LLC Bio Atla, Inc. Transaction History

Monashee Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$19.0 - $30.95 $3.39 Million - $5.53 Million	-178,600 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$29.44 - $43.74 $5.26 Million - $7.81 Million	178,600 New	178,600 $5.26 Million
Q1 2021 May 14, 2021	SELL	$32.41 - $70.91 $648,199 - $1.42 Million	-20,000 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$31.02 - $35.16 $620,400 - $703,199	20,000 New	20,000 $680,000

23.4M

30.8K

57K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $14.9M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.